Form 4 for OSTX OS Therapies Inc
Accepted 2025-02-28 00:00:00 ET · period of report 2025-02-28 · accession 0001213900-25-018889 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-28 | 2025-02-28 | OSTX | Romness Paul A. | Pres, CEO, Dir, 10% | J - Other | $0.00 | +225.0K | 2.47M | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 per share | 2025-02-28 | J | A | 225,000 | $0.00 | 2,473,000 | D | — | — | (F1) Pursuant to a Transfer Agreement, effective as of May 13, 2024 (the "Transfer Agreement"), between Einodmil LLC ("Einodmil") and the reporting person, 600,000 shares of the issuer's common stock owned by the reporting person were placed in escrow in exchange for Einodmil's participation in a pre-IPO lock-up agreement. The Transfer Agreement, entered into in connection with the issuer's initial public offering, outlined conditions for distributing the 600,000 shares after expiration of the lock-up period, based on the 20-day VWAP of the issuer's common stock. On February 28, 2025, 225,000 of these shares were released from escrow and transferred to the reporting person. The remaining 375,000 shares were released from escrow and transferred to Einodmil. |